Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$338M |
| 2 |
Visa
V
|
+$279M |
| 3 |
Microsoft
MSFT
|
+$277M |
| 4 |
Union Pacific
UNP
|
+$277M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$440M |
| 2 |
Palo Alto Networks
PANW
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$281M |
| 4 |
Cognizant
CTSH
|
+$280M |
| 5 |
CrowdStrike
CRWD
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HYI
3226
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
| $447K | ﹤0.01% |
35,783
-19,108
| -35% | -$229K |
|
|
BTX
3227
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
| $446K | ﹤0.01% |
65,483
-10,203
| -13% | -$72.8K |
|
3228
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$608M
| $445K | ﹤0.01% |
44,766
-9,863
| -18% | -$100K |
|
|
SGMO
3229
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $443K | ﹤0.01% |
141,074
+6,384
| +5% | +$24.8K |
|
|
NCZ
3230
Virtus Convertible & Income Fund II
NCZ
$306M
| $442K | ﹤0.01% |
38,355
-12,684
| -25% | -$150K |
|
3231
Radware
RDWR
$1.25B
| $440K | ﹤0.01% |
22,288
-6,046
| -21% | -$126K |
|
3232
Blue Ridge Bankshares
BRBS
$336M
| $440K | ﹤0.01% |
+35,236
| New | +$456K |
|
3233
J. Jill
JILL
$283M
| $440K | ﹤0.01% |
17,742
-90
| -0.5% | -$1.99K |
|
3234
Perimeter Solutions
PRM
$5.53B
| $439K | ﹤0.01% |
48,053
+98
| +0.2% | +$863 |
|
3235
Aclaris Therapeutics
ACRS
$863M
| $438K | ﹤0.01% |
27,783
-1,202
| -4% | -$19.3K |
|
3236
Forum Energy Technologies
FET
$927M
| $436K | ﹤0.01% |
14,795
-75
| -0.5% | -$2.05K |
|
3237
Urban One Class D
UONEK
$24.1M
| $436K | ﹤0.01% |
11,597
+1,591
| +16% | +$70.6K |
|
3238
JFrog
FROG
$11.5B
| $435K | ﹤0.01% |
20,399
+104
| +0.5% | +$2.36K |
|
3239
Amplify Energy
AMPY
$200M
| $433K | ﹤0.01% |
49,263
-218,220
| -82% | -$1.86M |
|
|
LOGC
3240
DELISTED
ContextLogic
LOGC
| $433K | ﹤0.01% |
29,596
+111
| +0.4% | +$2.28K |
|
3241
Arcturus Therapeutics
ARCT
$223M
| $430K | ﹤0.01% |
25,346
-988
| -4% | -$17.2K |
|
3242
PubMatic
PUBM
$787M
| $429K | ﹤0.01% |
33,486
+14,814
| +79% | +$232K |
|
3243
Lemonade
LMND
$4.1B
| $427K | ﹤0.01% |
31,226
+64
| +0.2% | +$1.26K |
|
|
JHI
3244
John Hancock Investors Trust
JHI
$118M
| $427K | ﹤0.01% |
34,059
-841
| -2% | -$10.6K |
|
3245
FerroAtlántica
GSM
$818M
| $425K | ﹤0.01% |
110,490
-14
| -0% | -$70 |
|
|
SMMF
3246
DELISTED
Summit Financial Group, Inc.
SMMF
| $425K | ﹤0.01% |
+17,057
| New | +$470K |
|
3247
Asana
ASAN
$2.28B
| $424K | ﹤0.01% |
30,825
-3,002
| -9% | -$54.5K |
|
3248
Nexa Resources
NEXA
$1.9B
| $424K | ﹤0.01% |
70,377
+77
| +0.1% | +$418 |
|
3249
WisdomTree US MidCap Dividend Fund
DON
$4.11B
| $424K | ﹤0.01% |
10,299
+1,156
| +13% | +$47.8K |
|
3250
Compañía de Cervecerías Unidas
CCU
$2.16B
| $423K | ﹤0.01% |
32,244
-1,084
| -3% | -$12.5K |
|
Similar funds
Invesco's Q4 2022 Portfolio in Review
As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
- Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
- Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
- Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
- Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
- Invesco opened 147 new positions and closed 115 in Q4 2022.
- Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.